每年研究成果
每年研究成果
研究成果
- 48 引文
- 3 h-指數
- 5 文章
搜尋結果
-
2021
High-grade b-cell lymphoma (Hgbl) with myc and bcl2 and/or bcl6 rearrangements is predominantly bcl6-rearranged and bcl6-expressing in Taiwan
Tsai, C. C., Su, Y. C., Bamodu, O. A., Chen, B. J., Tsai, W. C., Cheng, W. H., Lee, C. H., Hsieh, S. M., Liu, M. L., Fang, C. L., Lin, H. T., Chen, C. L., Yeh, C. T., Lee, W. H., Ho, C. L., Lai, S. W., Tzeng, H. E., Hsieh, Y. Y., Chang, C. L., Zheng, Y. M. 及其他4, , 四月 1 2021, 於: Cancers. 13, 7, 1620.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
2018
4-acetyl-antroquinonol B suppresses SOD2-enhanced cancer stem cell-like phenotypes and chemoresistance of colorectal cancer cells by inducing hsa-miR-324 re-expression
Bamodu, O. A., Yang, C. K., Cheng, W. H., Tzeng, D. T. W., Kuo, K. T., Huang, C. C., Deng, L., Hsiao, M., Lee, W. H. & Yeh, C. T., 八月 10 2018, 於: Cancers. 10, 8, 269.研究成果: 雜誌貢獻 › 文章 › 同行評審
14 引文 斯高帕斯（Scopus） -
HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1
Bamodu, O. A., Kuo, K. T., Yuan, L. P., Cheng, W. H., Lee, W. H., Ho, Y. S., Chao, T. Y. & Yeh, C. T., 九月 15 2018, 於: Experimental Cell Research. 370, 2, p. 519-530 12 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
19 引文 斯高帕斯（Scopus） -
2017
Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10
Cheng, W., Huang, P. C., Chao, H. M., Jeng, Y. M., Hsu, H. C., Pan, H. W., Hwu, W. L. & Lee, Y. M., 一月 1 2017, 於: Oncotarget. 8, 46, p. 80429-80442 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
3 引文 斯高帕斯（Scopus） -
2014
Prognostic factors in adult patients with solid cancers and bone marrow metastases
Hung, Y. S., Chou, W. C., Chen, T. D., Chen, T. C., Wang, P. N., Chang, H., Hsu, H. C., Shen, W. C., Cheng, W. H. & Chen, J. S., 一月 1 2014, 於: Asian Pacific Journal of Cancer Prevention. 15, 1, p. 61-67 7 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取12 引文 斯高帕斯（Scopus）